Earnings Call · Q3 FY2022·2022-11-03

Q3 22EPS +3.70%·Rev n/aQ2 22EPS -30.00%·Rev n/aQ1 22EPS -19.23%·Rev n/aQ4 21EPS -20.59%·Rev n/a⚠ consensus missing

IRONWOOD PHARMACEUTICALS INC IRWD

Matt Roache — Director of Investor Relations

Tom McCourt — Chief Executive Officer

Mike Shetzline — Chief Medical Officer

Sravan Emany — Chief Financial Officer

+3.6%1d on move date+4.7% vs SPY3d+7.3%5d+3.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IRWD calls or request research access.

More IRWD calls Browse calls Request research access